Factors influencing change of preoperative treatment intent in a gastrointestinal cancer practice

per Schwarz, Roderich E
Publicat 2007

Clinical trends and effects on quality metrics for surgical gastroesophageal cancer care

per Schwarz, Roderich E.
Publicat a Transl Gastroenterol Hepatol (2018)

Collision tumor in form of primary adenocarcinoma and neuroendocrine carcinoma of the duodenum

per Peng, Lan, Schwarz, Roderich E.
Publicat 2012

Profile of nintedanib in the treatment of solid tumors: the evidence to date

per Awasthi, Niranjan, Schwarz, Roderich E
Publicat a Onco Targets Ther (2015)

Vascular challenges from pancreatoduodenectomy in the setting of coeliac artery stenosis

per Beane, Joal D, Schwarz, Roderich E
Publicat a BMJ Case Rep (2017)

Experience with a simplified feeding jejunostomy technique for enteral nutrition following major visceral operations

per Minarich, Michael J., Schwarz, Roderich E.
Publicat a Transl Gastroenterol Hepatol (2018)

Proteasome inhibition enhances antitumour effects of gemcitabine in experimental pancreatic cancer

per Awasthi, Niranjan, Schwarz, Margaret A, Schwarz, Roderich E
Publicat 2009

Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer

per Awasthi, Niranjan, Schwarz, Margaret A, Schwarz, Roderich E
Publicat 2011

Pancreatoduodenectomy with or without Pyloric Preservation: A Clinical Outcomes Comparison

per Dineen, Sean P., Roland, Christina L., Schwarz, Roderich E.
Publicat 2008

AHPBA/SSO/SSAT Sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma

per Dixon, Elijah, Abdalla, Eddie, Schwarz, Roderich E, Vauthey, Jean-Nicolas
Publicat 2010

Augmentation of nab-paclitaxel chemotherapy response by mechanistically diverse antiangiogenic agents in preclinical gastric cancer models

per Awasthi, Niranjan, Schwarz, Margaret A., Zhang, Changhua, Schwarz, Roderich E.
Publicat a Mol Cancer Ther (2018)

The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer

per ZHANG, CHANG-HUA, AWASTHI, NIRANJAN, SCHWARZ, MARGARET A., SCHWARZ, RODERICH E.
Publicat 2013

Cell Proliferation and Migration Are Modulated by Cdk-1-Phosphorylated Endothelial-Monocyte Activating Polypeptide II

per Schwarz, Margaret A., Thornton, Janet, Xu, Haiming, Awasthi, Niranjan, Schwarz, Roderich E.
Publicat 2012

Evaluation of Poly-Mechanistic Antiangiogenic Combinations to Enhance Cytotoxic Therapy Response in Pancreatic Cancer

per Awasthi, Niranjan, Zhang, Changhua, Ruan, Winston, Schwarz, Margaret A., Schwarz, Roderich E.
Publicat 2012

Superior Antitumor Activity of Nanoparticle Albumin-Bound Paclitaxel in Experimental Gastric Cancer

per Zhang, Changhua, Awasthi, Niranjan, Schwarz, Margaret A., Hinz, Stefan, Schwarz, Roderich E.
Publicat 2013

Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II

per Awasthi, Niranjan, Zhang, Changhua, Hinz, Stefan, Schwarz, Margaret A, Schwarz, Roderich E
Publicat 2013

AHPBA/SSO/SSAT sponsored consensus conference on the multidisciplinary treatment of colorectal cancer metastases

per Schwarz, Roderich E, Abdalla, Eddie K, Aloia, Thomas A, Vauthey, Jean-Nicolas
Publicat 2013

Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer

per Awasthi, Niranjan, Monahan, Sheena, Stefaniak, Alexis, Schwarz, Margaret A., Schwarz, Roderich E.
Publicat a Oncotarget (2017)

The N Terminus of Pro-endothelial Monocyte-activating Polypeptide II (EMAP II) Regulates Its Binding with the C Terminus, Arginyl-tRNA Synthetase, and Neurofilament Light Protein

per Xu, Haiming, Malinin, Nikolay L., Awasthi, Niranjan, Schwarz, Roderich E., Schwarz, Margaret A.
Publicat a J Biol Chem (2015)

Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer

per Awasthi, Niranjan, Hinz, Stefan, Brekken, Rolf A., Schwarz, Margaret A., Schwarz, Roderich E.
Publicat a Cancer Lett (2014)